4th International Workshop on Clinical Pharmacology of HIV Therapy, 27-29 March 2003, Cannes, France
1 May 2003. Related: Conference reports, PK and drug interactions.
PK Workshop 4th Cannes 2003
Can low NVP plasma concentrations explain the results seen in the EFV and NVP containing arms of the NARVAL study?
1 May 2003. Related: Conference reports, PK and drug interactions.
Up to one third of patients receiving standard doses of NNRTIs may be being underdosed
1 May 2003. Related: Conference reports, PK and drug interactions.
Nelfinavir concentrations are significantly higher in HIV/HCV co-infected patients with cirrhosis
1 May 2003. Related: Conference reports, PK and drug interactions.
Less diarrhoea and bioequivalence with the new nelfinavir 625mg tablet
1 May 2003. Related: Conference reports, Antiretrovirals, PK and drug interactions, Side effects.
The potential for probenecid to have a serious interaction with HIV-1 protease inhibitors
1 May 2003. Related: Conference reports, PK and drug interactions, Side effects.
PK studies reveal significant sex/gender differences
1 May 2003. Related: Conference reports, Women's health, PK and drug interactions.
Pregnancy-related PK studies
1 May 2003. Related: Conference reports, Pregnancy, PK and drug interactions.
New test to measure intracellular levels of nucleosides
1 May 2003. Related: Conference reports, PK and drug interactions.
Case studies for therapeutic drug monitoring (TDM)
1 May 2003. Related: Conference reports, PK and drug interactions.
Launch of guide to the use of drug level monitoring
1 May 2003. Related: Conference reports, PK and drug interactions.